Dafna Capital Management LLC Oramed Pharmaceuticals Inc. Transaction History

Dafna Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.43 - $5.74 $38,880 - $91,840	-16,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.88 - $4.36 $28,800 - $43,600	-10,000 Reduced 38.46%	16,000 $57,000
Q1 2019 May 15, 2019	BUY	$2.95 - $3.64 $29,500 - $36,400	10,000 Added 62.5%	26,000 $95,000
Q4 2018 Feb 14, 2019	BUY	$3.0 - $4.94 $48,000 - $79,040	16,000 New	16,000 $48,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.